Sponsor Pipeline

Shi Tianming Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Phase 3
Active Trials by Phase
Phase 2/3
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07435090 Efficacy and Safety of Rimegepant for Acute Dizziness Dizziness Not Yet Recruiting
Get alerts when Shi Tianming's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free